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Introduction 
The lung is the major site for the origin 
of small cell carcinoma. Pulmonary small 
cell carcinoma of the lung comprises 20% of 
all lung cancers.1-3 However, extra-
pulmonary small cell carcinoma has been 
recognized as a separate entity.1 Sites 
include the esophagus, thymus, stomach, 
pancreas, and the cervix. Extrapulmonary 
small cell carcinomas comprise only 2.5 to 
4.1% of all small cell carcinomas.1-3 Thus, 
primary small cell carcinoma of the liver is a 
rare entity. We compare the clinical course, 
pathology/immunohistochemical findings 
and treatment response among reported 
cases in literature.  
 
Case Report 
A 63-year-old woman presented with 
right upper quadrant pain of gradual onset. 
She denied any associated symptoms 
including, but not limited to, nausea, 
vomiting, diarrhea, fever, chills, and 
hematemesis. Her prior history included 
hepatitis C, osteoarthritis, deep vein 
thrombosis, and pulmonary embolism. She 
smoked for 20 years. Her physical exam 
revealed mild tenderness in the right 
hypochondrium and the liver edge was 
palpable 1 cm below right costal margin.  
A complete blood count and compre-
hensive metabolic panel were normal. A 
computed tomography (CT) scan of the 
abdomen showed a 8.6 x 7.6 cm mass in 
right lobe of the liver (see Figure 1) with 
extension in the  intrahepatic  portion  of  the 
 
portal vein along with celiac adenopathy. 
Her alfa-fetoprotein was 3.48 ng/ml (0 - 6.1 
ng/ml), carcinoembryonic antigen was 3.8 
mg/L (0 - 5 mg/L), CA-19-9 was 86 U/ml (< 
37 U/ml) and her anti-HCV was positive. 
Liver biopsy results were consistent with 
small cell carcinoma.   
  
 
Figure 1. Arrows show a 8.6 x 7.6 cm mass in 
right lobe of the liver. 
 
In search of the primary site, a chest X-
ray, CT of the chest, and positron emission 
tomography (PET) scan were done. All were 
negative for any pulmonary lesion. 
Diagnosis of extrapulmonary small cell 
carcinoma of the liver was made and the 
patient was started on chemotherapy 
including carboplatin and etoposide.   
Microscopically, the extrapulmonary 
small cell carcinoma of the liver tumor 
exhibited minimal cytoplasm, inconspicuous 
nucleoli, and diffuse nuclear hyper-
chromasia. Immunohistochemical staining 
showed strong positivity for synaptophysin 
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and patchy reactivity to CK7 but was 
negative for AE1:3, chromogranin, CD20, 
CD3, HepPar1, TTF-1, CK20, and cirrhosis 
(Figures 2 and 3). 
The patient died within 30 days of 
diagnosis. 
 
 
Figure 2. Tumor cells under high resolution 
(see arrows). 
 
 
Figure 3. Arrows show positive synapto-
physin stain. 
 
Discussion 
Extrapulmonary small cell carcinoma 
comprises 0.1 to 0.4% of all cancers.4 Small 
cell carcinoma of the liver is extremely rare 
and only 14 cases have been reported in the 
literature (see Table 1). Small cell carci-
noma can arise in any tissue of the body 
beside the lung and liver. Primary reported 
locations are neck, larynx, head, salivary 
glands, thyroid, trachea, larynx, esophagus, 
stomach, cervix, uterus, gall bladder, 
rectum, breast, and skin.1-3 More than 50% 
of extrapulmonary small cell carcinomas are 
located in the gastrointestinal tract.11 
Small cell carcinoma of the liver has a 
slight male predominance with a male to 
female ratio of 1.8:1; approximately 86% of 
patients were over 50 years at the time of 
presentation (Table 1). Most patients 
presented with upper abdominal pain, lump, 
loss of appetite, and jaundice. On the basis 
of histological appearance, it is very difficult 
to differentiate it from metastatic pulmonary 
small cell carcinoma; hence, it is mandatory 
to have a clear chest radiograph, CT scan of 
the chest, negative sputum cytology, and 
bronchoscopy or PET scan before making 
the diagnosis of primary tumor.6 
In most reported cases, the tumor 
showed neuroendocrine differentiation, with 
markers like enolase, synaptophysin and 
chromogranin. Most cases also reported 
CD56, thyroid transcription factor-1 (TTF-
1), c-kit, cytokeratin, and CEA. However, it 
is not necessary to find all markers in every 
case. Presence of vimentin, desmin, CD56, 
chromogranin, synaptophysin, and S-100 
protein is quite specific. Synaptophysin was 
positive in 100% of the cases and neuron 
specific enolase was positive in over 85% of 
the cases.  
Due to the small number of reported 
cases, conclusions about the characteristics 
of small cell carcinoma of the liver must not 
be made. Small cell carcinoma of the liver 
may present with weight loss, jaundice, and 
high AFP levels as key features.7 Features 
like absence of viremia, low AFP, and 
cirrhosis differentiate small cell carcinoma 
from the most predominant tumor of liver, 
hepatocellular carcinoma. 
Prognosis of the tumor is variable 
depending upon its stage and location. More 
than 90% of cases shown in Table 1 were 
diagnosed at an advanced age. Overall,
Kansas Journal of Medicine 2012             Primary Small Cell Carcinoma of Liver 
 
103 
 
Table 1.  Characteristics of patients with primary small cell carcinoma of liver. 
Authors Age / 
Sex 
Presentation Size (cm) Stage at 
Presentation 
AFP (ng/ml) Immuno- 
histochemical 
Staining 
Treatment 
 
Outcome 
Ryu et al.5 56 / Male Weakness, 
Upper 
abdominal 
pain 
8 Advanced 3.24 (+) CD56, C-kit, 
SYN 
(-) TTF-1 
CT 
(cisplastin, 
etopside, 
irinotecan) 
Unknown 
Kim et al.6 53 / Male Palpable mass 12 Advanced 2.94 (+) CD56, NSE, C-
kit, SYN, CK, 
EMA 
(-) CK 7, 8, 19, 20, 
AFP, CEA, TTF-1, 
Vimentin, Desmin) 
Segmentec-
tomy and CT 
(cisplastin, 
etopside) 
Unknown 
Zanconati 
et al.7 
56 / Male Abdominal 
pain 
5 Limited > 200 (+) AE1/ AE3, 
CK8, 18, 19, NSE, 
AFP, ERY-1 
(-) S-100 protein, 
CEA 
Partial 
hepatectomy 
Unknown 
Zanconati 
et al.7 
69 / Male Diabetes, 
Weight loss 
10 Advanced Unknown (+) AE1/AE3, CK8, 
18, 19 
(-) S-100 protein, 
CEA 
Unknown Died of 
disease 
Zanconati et 
al.7 
89 / Male Jaundice 6 Advanced 150 (+) AE1/AE3, CK8, 
18, 19, AFP, NSE 
(-) CK, CEA 
Unknown Died of 
disease 
Kim et al.8 67 / Male Abdominal 
pain 
12 Advanced Unknown (+) SYN, CD56, C-
kit 
(-) CK, CEA, AFP 
CT 
(cisplastin, 
epirubicin) 
Unknown 
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Sengoz et 
al.9 
73 / 
Female 
Unknown Unknown Advanced Unknown Unknown Right 
hepatectomy 
Died of 
disease 
Sengoz et 
al.9 
63 / Male Unknown Unknown Unknown Unknown Unknown CT 
(cisplastin) 
Died of 
disease 
Kim et al.1 Unknown Unknown Unknown Advanced Unknown (+) CHR, SYN Unknown Unknown 
Choi et al.10 82 / 
Female 
Abdominal 
discomfort 
6.7 Advanced 3.4 (+) CD56, NSE, 
SYN, CHR, TTF-1, 
C-kit 
(-) Anti-hepatocyte, 
AFP, Vimentin, 
Desmin, CK7, 19, 
20, CEA, S-100 
protein 
CT 
(cisplastin, 
etoposide) 
Unknown 
Morikawa et 
al.11 
77 / Male Fatigue, 
weakness 
10 Advanced 27 (+) AE1/AE5, 
CAM5.2 
(-) NSE, Desmin, 
Vimentin, CEA 
CT 
(cisplastin, 
etoposide) 
Died of 
disease 
Yang-Qing 
Huang et 
al.12 
34 / Male Incidental 
finding 
Unknown Unknown Unknown Unknown Right 
hepatectomy, 
segment I 
excision, and 
TACE for 
recurrence 
Unknown 
Kaman et 
al.13 
40 / 
Female 
Pain and 
abdominal 
lump 
13.5 Advanced 2.1 (+) NSE, SYN 
(-) TTF-1, HepPar 
1, CEA 
Central 
bisectionec-
tomy and CT 
(cisplatin, 
etoposide) 
Unknown 
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RUQ = right upper quadrant, CT = Chemotherapy, AFP = Alpha-fetoprotein, CEA = Carcinoembryonic antigen, CHR = 
Chromogranin, CK = Cytokeratin, EMA = Epithelial membrane antigen, NSE = Neuron specific enolase, SYN = Synaptophysin, 
TTF-1 = Thyroid transcription factor, TACE = transcatheter arterial chemoembolization. 
 
Khaw et 
al.14 
51 / Male Incidental 
finding 
3.5 Localized Unknown (+) CD56, SYN, 
CHR 
Liver 
transplant-
ation 
Died of 
disease 
Our case 63 / 
Female 
RUQ pain 8.6 Advanced 3.5 (+) AE1, SYN, 
CHR, CD20, CD3 
(-) HepPar1, TTF-
1, CK20 
CT 
(carboplatin, 
etopside). 
Died of 
disease 
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limited disease has a better chance of cure 
than extensive disease.11 Treatment options 
depend upon the tumor staging, and include 
surgery, chemotherapy, and radiotherapy.  
Standard chemotherapy includes platinum- 
based therapy, same as that for pulmonary 
small cell carcinoma of the lung.  In the two 
cases reported by Sengoz et al.9, one patient 
was given chemotherapy and other was 
operated for right hepatectomy. Both 
patients survived for more than a year. Ryu 
et al.5 treated their patient with platinum- 
based chemotherapy.  The patient responded 
well to therapy. Out of seven deaths, five 
died within three months of diagnosis. Our 
patient was started on platinum-based 
chemotherapy, but unfortunately due to the 
aggressive nature of the disease, she died 
within a month after the diagnosis.  
 
Conclusion 
Small cell carcinoma of the liver is rare 
and details about etiology, risk factors, and 
treatment options are limited. Reporting 
more cases will help clinicians to understand 
the disease aggressiveness, treatment and 
prognosis.  
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